Cargando…

Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)

INTRODUCTION: The occurrence of the immunopreventable diseases in a population global reality. OBJECTIVE: To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and their areas, between 2008 and 2018. METHODS: A popu...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Élide Sbardellotto M., Hyeda, Adriano, Maluf, Eliane M. C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555006/
https://www.ncbi.nlm.nih.gov/pubmed/34706728
http://dx.doi.org/10.1186/s12913-021-07117-5
Descripción
Sumario:INTRODUCTION: The occurrence of the immunopreventable diseases in a population global reality. OBJECTIVE: To discriminate the direct costs of the hospitalizations from the immunopreventable diseases in the Unified Health System (SUS), in Brazil and their areas, between 2008 and 2018. METHODS: A population, observational, descriptive and retrospective study, with data from the information supplied by the DATASUS website, these data were collected during the 2019. RESULTS: It was identified 457,479 hospitalizations in the period; with a total of 2,450,870 days of hospital stay, with total costs of R$389,243,264.85. Only the disease mumps presented a growing tendency in whole areas; the chickenpox was decreasing; the illness whooping cough, yellow fever and tetanus were stationary in this period. CONCLUSIONS: The costs related to immunopreventable diseases were relevant in all the Brazil areas, with tendencies different between the geographic areas and between the several illnesses analysed.